FDA approves new drug for hyperkalemia
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved eltassa (patiromer for oral suspension) to treat hyperkalemia. Read more.
Web Exclusives
FDA approves new drug for pancreatic cancer
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to treat patients…
Marijuana use more than doubles from 2001 to 2013
The estimated prevalence of adults who used marijuana in the past year more than doubled in the U.S. between 2001 and 2013 to 9.5%,…
AHA releases new CPR guidelines
The American Heart Association has published new guidelines for CPR and emergency cardiovascular care. Read a quick summary, download a PDF with the highlights,…
FDA approves new drug for metastatic lung cancer
On Oct. 9, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to treat patients with metastatic non-small cell lung cancer whose disease…
Older adults feel burden of healthcare system
Nearly four in ten older adults say that managing their health care needs is difficult for them or their families, that medical appointments or…
Strategies for managing “weekend effect” of surgeries
According to a study in Annals of Surgery, the following resources can help address the fact that patients who undergo urgent surgeries on weekends…
FDA approves new injectable drug for schizophrenia
On Oct. 6, the U.S. Food and Drug Administration (FDA) approved Aristada (aripiprazole lauroxil) extended-release injection to treat adults with schizophrenia. Read more
FDA launches campaign to reduce youth smoking
On Oct. 7, the U.S. Food and Drug Administration (FDA) announced the launch of a national public education campaign to prevent and reduce tobacco…
FDA approves new drugs for diabetes
On Sept. 25, the U.S. Food and Drug Administration (FDA) approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve…
WHO issues new HIV treatment recommendations
According to a new guideline from the World Health Organization (WHO), anyone infected with HIV should begin antiretroviral treatment as soon after diagnosis as…
The Joint Commission issues Sentinel Event Alert on falls
The Joint Commission has released “Sentinel Event Alert 55: Preventing falls and fall-related injuries in health care facilities,” which includes tools and resources. Read…
FDA approves new drug for hyperkalemia
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved eltassa (patiromer for oral suspension) to treat hyperkalemia. Read more.
FDA approves new drug for pancreatic cancer
On Oct. 22, the U.S. Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection), in combination with fluorouracil and leucovorin, to…
Marijuana use more than doubles from 2001 to 2013
The estimated prevalence of adults who used marijuana in the past year more than doubled in the U.S. between 2001 and 2013…
AHA releases new CPR guidelines
The American Heart Association has published new guidelines for CPR and emergency cardiovascular care. Read a quick summary, download a PDF with…
FDA approves new drug for metastatic lung cancer
On Oct. 9, the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) to treat patients with metastatic non-small cell lung cancer…
Older adults feel burden of healthcare system
Nearly four in ten older adults say that managing their health care needs is difficult for them or their families, that medical…
Strategies for managing “weekend effect” of surgeries
According to a study in Annals of Surgery, the following resources can help address the fact that patients who undergo urgent surgeries…
FDA approves new injectable drug for schizophrenia
On Oct. 6, the U.S. Food and Drug Administration (FDA) approved Aristada (aripiprazole lauroxil) extended-release injection to treat adults with schizophrenia. Read…
FDA launches campaign to reduce youth smoking
On Oct. 7, the U.S. Food and Drug Administration (FDA) announced the launch of a national public education campaign to prevent and…
FDA approves new drugs for diabetes
On Sept. 25, the U.S. Food and Drug Administration (FDA) approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection)…
WHO issues new HIV treatment recommendations
According to a new guideline from the World Health Organization (WHO), anyone infected with HIV should begin antiretroviral treatment as soon after…
The Joint Commission issues Sentinel Event Alert on falls
The Joint Commission has released “Sentinel Event Alert 55: Preventing falls and fall-related injuries in health care facilities,” which includes tools and…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.